Ma. Vanefsky et al., Correlation of magnetic resonance characteristics and histopathological type of angiographically occult vascular malformations, NEUROSURGER, 44(6), 1999, pp. 1174-1180
OBJECTIVE: Histological and radiological classification of vascular malform
ations has previously been attempted in an effort to understand their natur
e and predict their biological behavior. There exists a subgroup of vascula
r malformations that are angiographically occult and share a common magneti
c resonance imaging (MRI) appearance but may differ in their behavior. We s
ought to determine any correlation between MRI features and final histopath
ological diagnosis.
METHODS: We reviewed our series of 72 patients with angiographically occult
vascular malformations operated on at Stanford University Medical Center b
etween 1988 and 1993. Radiographic magnetic resonance images and histopatho
logical specimens were retrospectively evaluated for various diagnostic fea
tures.
RESULTS: Our data indicate that lesions exhibiting a ring of hemosiderin ar
e associated with the presence of a cavernous malformation (CM) component (
86% of CMs versus 33% of non-CM lesions). A lesion associated with edema, m
ass effect, or a single prominent blood product on MRI correlates with the
presence of an arteriovenous malformation (AVM) component. Sixty-three perc
ent of AVMs and 80% of lesions with partial AVM components showed edema, co
mpared with 8% of CMs and 0% of venous malformations. Sixty percent of AVMs
and 63% of lesions with partial AVM components showed a single prominent b
lood product, compared with 8% of CMs and 0% of venous malformations. Final
ly, 60% of AVMs exhibited mass effect, compared with 20% of CMs. Additional
ly, an expansile hemorrhage is suggestive of an AVM.
CONCLUSION: This study is the first to demonstrate that a particular MRI ap
pearance of an angiographically occult vascular malformation is suggestive
of an AVM component. This may have important implications with regard to th
e behavior of the lesion and planning of future treatment.